Renovaro Biosciences's total assets for Q1 2024 were $121.83M, a decrease of -25.32% from the previous quarter. RENB total liabilities were $23.75M for the fiscal quarter, a -23.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.